Press Releases

Tubulis Welcomes Mary Ann Lumiqued as Vice President Program Management

MUNICH, GERMANY, July 11, 2022 – The Tubulis team continues to grow, and we are excited to welcome Mary Ann Lumiqued as our new Vice President Program Management! Mary Ann brings more than 20 years of experience in the management of drug development and commercialization projects as well as in the development and execution of medical affairs strategies to Tubulis. Previously, she worked in leading positions for private and public life sciences companies, including Ipsen and Morphosys, where she successfully directed and implemented product development and brand strategy plans. At Tubulis, Mary Ann will use her extensive know-how to advance the development plans for our uniquely matched ADCs.


For Tubulis
Dominik Schumacher,
CEO & Co-Founder
Phone: +49 175 800 5594

Media Requests for Tubulis
Trophic Communications
Stephanie May or Marie Weickert
Phone: + 49 171 185 5682

Share Article

More Press Releases

Tubulis Presents Preclinical Data for Solid Tumor Targeting ADC Candidates TUB-030 and TUB-040 Demonstrating Superior Efficacy Profile and a Wide Therapeutic Window at the AACR Annual Meeting 2024

Tubulis Closes Upsized €128 Million Series B2 to Accelerate Clinical Development of Solid Tumor-Focused ADC Pipeline

Tubulis to Present Preclinical Proof-of-Concept Data for Two Lead ADC Candidates Targeting Solid Tumors at the AACR Annual Meeting 2024